205187-53-7

Upstream product

• 1000783-89-0 C₁₄H₈F₄O₂S 
• 23382-09-4 silicon dioxide hydrate 
• 353-83-3 1,1,1-trifluoro-2-iodoethane 

Relevant academic research and scientific papers

POLYMORPHIC FORM OF FLUORO-7-(2,2,2-TRIFLUOROETHOXY) PHENOXATHIIN-10,10-DIOXIDE

Provided herein is a new form of 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathin 10,10-dioxide, which demonstrates higher stability relative to other forms of 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiin-10,10-dioxide. In particular, this new form affords

Phenoxathiin derivatives as inhibitors of monoamine oxidase

PCT No. PCT/US97/23486 Sec. 371 Date Mar. 11, 1999 Sec. 102(e) Date Mar. 11, 1999 PCT Filed Aug. 19, 1997 PCT Pub. No. WO98/12190 PCT Pub. Date Mar. 26, 1998The present invention provide phenoxathiin compounds useful in the prophylaxis and treatment of mental disorders, such as depression. The present invention also provides a method for treating a mammal having depression, anxiety or other conditions responsive to inhibition of MAO-A. A method of preparing the compounds of the present invention is also provided.